Astrana Health, Inc. (ASTH) stock
ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/307% below fair value
$31.80+0.03 (+0.09%)
Close on Nov 13, 2026Market cap $1.77BP/E 29.7Yield –
Astrana Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Astrana Health's total debt was $925.38M at Sep 30, 2026. For fiscal 2025 it was $1.04B, up 139.0% from the year before. The highest annual figure on record is $1.04B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.04B | +139.0% |
| FY2024 | Dec 31, 2024 | $434.67M | +56.1% |
| FY2023 | Dec 31, 2023 | $278.44M | +36.5% |
| FY2022 | Dec 31, 2022 | $204.01M | +11.1% |
| FY2021 | Dec 31, 2021 | $183.70M | -23.8% |
| FY2020 | Dec 31, 2020 | $241.10M | -0.2% |
| FY2019 | Dec 31, 2019 | $241.67M | – |
| FY2018 | Dec 31, 2018 | $0 | -100.0% |
| FY2016 | Mar 31, 2016 | $200.00K | – |
| FY2014 | Jan 31, 2014 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $925.38M | -11.9% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $936.50M | +126.4% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $1.03B | +146.8% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $1.04B | +139.0% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $1.05B | +139.6% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $413.56M | -6.4% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $416.39M | +7.0% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $434.67M | +56.1% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $438.12M | +109.4% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $442.01M | +112.7% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $389.20M | +89.3% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $278.44M | +36.5% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $209.20M | +3.4% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $207.77M | +3.1% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $205.57M | +11.4% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $204.01M | +11.1% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $202.31M | +10.5% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $201.48M | +10.2% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $184.60M | -22.8% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $183.70M | -23.8% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $183.02M | -22.3% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $182.91M | -23.8% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $239.02M | -0.2% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $241.10M | -0.2% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $235.55M | -3.3% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $239.96M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $239.61M | +119702.5% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $241.67M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $243.65M | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $0 | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | $200.00K | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | $0 | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | $0 | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | $0 | – |
| Q4 FY2014CQ4 2013 | Jan 31, 2014 | $0 | – |
See a number that looks wrong?